Abstract
The fouling resistance of zwitterionic coatings is conventionally explained by the strong hydrophilicity of such polymers. Here, the in vitro biocompatibility of a set of systematically varied amphiphilic, zwitterionic copolymers is investigated. Photocrosslinkable, amphiphilic copolymers containing hydrophilic sulfobetaine methacrylate (SPe) and butyl methacrylate (BMA) were systematically synthesized in different ratios (50:50, 70:30, and 90:10) with a fixed content of photo-crosslinker by free radical copolymerization. The copolymers were spin-coated onto substrates and subsequently photocured by UV irradiation. Pure pBMA and pSPe as well as the prepared amphiphilic copolymers showed BMA content-dependent wettability in the dry state, but overall hydrophilic properties a fortiori in aqueous conditions. All polysulfobetaine-containing copolymers showed high resistance against non-specific adsorption (NSA) of proteins, platelet adhesion, thrombocyte activation, and bacterial accumulation. In some cases, the amphiphilic coatings even outperformed the purely hydrophilic pSPe coatings.
1 Introduction
Central venous or arterial catheters in permanent blood contact, chest drains, drainage tubes for draining bile, pancreatic secretions, urine or for draining wound fluids, or stents for keeping the ureters open and many other such medical devices have become indispensable in modern surgery or interventional medicine. (; ; ; ). Tubular systems used for the transport of body fluids are mostly based on non-biodegradable polymeric biomaterials (e.g., silicones, polyurethanes, etc.) () and only function adequately if their intraluminal diameter remains unchanged and is not constricted or even closed by protein/cell deposits (), clotted blood (), encrustations, (), or as a result of bacterial adhesion and biofilm formation. (). In order to prevent these adverse effects on the one hand, and to avoid triggering acute or chronic toxic or allergic reactions on the other, high demands are placed on biocompatible coatings for biomedical applications. By preventing non-specific adsorption (NSA) of proteins, the non-specific adhesion of human cells and other microorganisms can also be minimized. This improves hemocompatibility and reduces unwanted inflammatory or immune reactions.
The common approach is to use hydrophilic coatings such as polyethylene glycol-based materials because they are highly protein resistant due to their hydrophilic nature. However, the chemical nature of the polyethylene glycol (PEG) structure is prone to oxidation (; ; ), has shown in some instances to be immunogenic (; ), and provides little opportunity for chemical variations. Another popular class of hydrophilic polymers contains zwitterionic functional groups. (; ; ; ). Zwitterions are inspired by membranes of mammalian cells, which bear phospholipids and glycoproteins. (). Coatings based on phosphatidylcholines (PC), carboxybetaines (CB), sulfobetaines (SB), or sulfabetaines (SAB) incorporate negatively and positively charged groups, which induce strong electrostatic interactions with surrounding water molecules, while the overall charge is neutral. (; ; ; ). The type of functional groups, the orientation of the charged groups within the coating, and the overall architecture of the zwitterions enable a great variety of design and adaption flexibility for low fouling applications. (; ; ). Common applications of zwitterion-containing coatings are the usage in biosensors (; ) as well as for membranes. (; ; ; ). The addition of hydrophobic components into hydrophilic materials results in amphiphilic coatings which showed superior performance in several experiments. (; ; ; ; ; ). Polymers composed of PC and BMA exhibit a delayed coagulation time and reduced protein adsorption compared to polymers made solely of BMA. (). Copolymers of ∼30% CB and ∼70% BMA showed high resistance against fibrinogen (Fb) adsorption. (). In other experiments less systematic trends were observed, as the polybetaines combined with hydrophilic PEG or lipophobic fluorinated residues showed low NSA of proteins while polybetaines with lipophilic alkyl residues showed a higher NSA of proteins. (; ).
The PC motif is known to improve the hemocompatibility of polymers. (; ; ; ; ). For example, Ishihara et al. have co-polymerized 2-methacryloyloxyethyl phosphorylcholine (MPC) with butyl methacrylate (BMA) and demonstrated that increasing the MPC contents improved the non-thrombogenicity of the polymer. (). Formulations based on this system with a molar PC content of about 30 mol% are nowadays commercially available as blood-compatible coatings for medical purposes (LIPIDURE-CM5206). (; ; ). Similarly, CB functionalized monomers were copolymerized with BMA in different ratios to produce different amphiphilic coatings. Coatings with 30 mol% CB showed the best resistance against NSA of fibrinogen, and also demonstrated resistance against albumin, γ-globulin, and serum. Copolymers with more than 30 mol% CB units easily dissolved in an aqueous solution, and therefore, lost their ability to act as a protective coating. (). In a different study, amphiphilic coatings containing 30% CB monomers were copolymerized with different hydrophobic components. All copolymers showed superior low fouling and thrombogenic response compared to uncoated materials. (). To enhance the stability of zwitterionic polymers, Lin and co-workers co-polymerized MPC/BMA with photoreactive benzophenone-based methacrylate. The co-polymer was photo-crosslinked by UV radiation and showed high resistance against NSA of fibrinogen and HeLa cells. (). Another study copolymerized methacrylate-based SB in combination with N-isopropylacrylamide (NIPAM) in different ratios. The higher the content of zwitterions in the resulting copolymers, the better the resistance to NSA of proteins, platelets, and human fibroblasts, while increased NIPAM content leads to improved thermosensitivity. (). Still, despite these promising findings, several theoretical and experimental studies emphasize the view, that the ways of interaction of water molecules with different zwitterionic moieties vary substantially. (). According to these different modes of interactions, different levels of efficiency in their anti-fouling performance have been discussed. Mostly, PC-based coatings have been postulated to be the best, yet the experimental base for such comparisons is small. (; ). PC-moieties pose the risk of hydrolytic cleavage in a biological environment. (). Comparing CB and SB moieties, both have a high hydration capacity but SB is less sensitive to different ions and pH changes and has still only a moderate self-assembling effect. (; ; ).
While the combination of PC-methacrylates with BMA showed promising properties, combinations of SB-methacrylates with BMA have not yet been explored regarding “in vitro biocompatibility.” We recently synthesized a series of photocrosslinkable coatings containing SPe and BMA components in different ratios and evaluated them in the context of marine fouling. Our results show that the effectiveness of these amphiphilic coatings varies significantly depending on the specific combination of copolymer and fouling organisms. (). In order to evaluate their utility as potential medical coating comprehensively, it is necessary to extend the studies with respect to resistance to biological cells and blood components. In the present work, the proportions of 3-(N-(2-methacryloyloxy)ethyl-N,N-dimethylammonio)-propane-1-sulfonate (SPe) and n-butyl methacrylate (BMA) were systematically varied from approximately 50, 70, and 90% SPe mixed with 50, 30% and 10% BMA and were compared to pure pSPe and pBMA. Each coating contained approx. 1 mol% of 2-(4-benzoylphenoxy) ethyl methacrylate (BPEMA) as a photoreactive crosslinker to enhance its stability. The produced homogeneous and well-defined SPe/BMA coatings with systematically varied hydrophobic content were analyzed regarding their long-term stability in phosphate-buffered saline (PBS) solution and their resistance to the NSA of human serum albumin (HSA) and fibronectin (Fn). Furthermore, the adhesion of L929 mouse fibroblasts and primary human thrombocytes as well as their aggregation and activation could be prevented. In addition, these coatings showed no hemolysis of erythrocytes nor leucocyte activation. Also, the prevention of Escherichia coli adhesion was shown to be a significant and beneficial property for practical clinical applications.
2 Materials and methods
2.1 Chemicals
2,2,2-trifluoroethanol (TFE, 99,8%, Carl Roth, Germany), 3-aminopropyltrimethoxysilane (APTMS, 97%, Sigma Aldrich, United States), 11-aminoundecane thiol hydrochloride (AUDT, ProChimia Surfaces, Poland), acetone (HPLC grade, Alfa Aesar, United States), ethanol (analytical reagent grade, Fisher Scientific, United States), hydroxyhexaethyleneglycol-1-undecanethiol (EG6OH, ProChimia Surfaces, Poland), albumin from human serum (HSA, lyophilized powder, 97%–99%, Sigma-Aldrich, United States), fibronectin from human plasma (Fn, lyophilized powder, ≥95%, Sigma-Aldrich, United States), 1-dodecanethiol (DDT, Sigma-Aldrich United States), 3-(N-(2-methacryloyloxy)ethy-N,N-dimethylammonio)propane-1-sulfonate (SPe, Sigma-Aldrich, ≥97%), 2-(4-Benzoylphenoxy)ethyl methacrylate (BPEMA, a gift from Michael Pach, IAP Fraunhofer Potsdam/Germany), Müller-Hinton-Boullion (Carl Roth, Karlsruhe, Germany), nutrient agar (Carl Roth, Karlsruhe, Germany), phosphate-buffered saline (10× PBS, pH = 7.4, Fisher Scientific, United States), and LIVE/DEAD™ BacLight™ (propidium iodide, SYTO 9 (Thermo Fisher Scientific, United States) were used without further purification. Butyl methacrylate (BMA, Sigma Aldrich, containing 10 ppm of monomethylhydroquinone “MEHQ” as an inhibitor) was distilled before used. Water was purified with a Milli-Q system (Siemens Water Technology, Germany). Coatings (∼100 nm thickness) were prepared on silicon wafers (Siegert Wafer, Germany) for thickness determination, on glass (Nexterion Slide Glass B or D263, Schott, Germany) for biological experiments and captive bubble contact angle goniometry, or on gold-coated glass slides (Ti 5 nm + Au 60 nm) for protein resistance assessment by surface plasmon resonance spectroscopy.
2.2 Sample preparation
Silicon and glass substrates were modified with 3-aminopropyltrimethoxysilane (APTMS). Gold substrates were modified with a self-assembled monolayer of 11-amino-1-undecanethiol hydrochloride (AUDT) as adhesion-promoting layer according to previously established protocols. (; ; ). All samples were stored under inert atmosphere until further use. Copolymerization of 2-(4-benzoylphenoxy)-ethyl methacrylate (BPEMA) with the monomers n-butyl methacrylate (BMA), and 3-[N-2-(methacryloyloxy)ethyl-N, N-dimethyl]-ammonio propane-1-sulfonate (SPe) was conducted in different ratios by the usage of free radical copolymerization as previously described. (; ; ; ). Molecular characterization of the co-polymers including 1H-NMR, size exclusion chromatography, and UV-VIS spectroscopy was previously reported. (). Co-polymers were dissolved in 2,2,2-trifluoroethanol (TFE), spin-coated (10 s at 100 rpm followed by 30 s at 3,000 rpm) onto the different substrates and photo-crosslinked by UV-irradiation [Dr. Hönle AG, UVA Cube 100 (100 W) with Strahler UV 150F (150W)] following published protocols. (). Solutions of 1 wt% were used on pre-treated silicon and glass substrates for analytical characterization. Solutions of 0.5 wt% were applied on pre-treated gold substrates for protein resistance analysis. Co-polymerized compounds are indicated using the prefix p when exclusively BMA or SPe is used in combination with BPEMA or cop when BMA and SPe are used in different ratios in combination with BPEMA.
2.3 Contact angle goniometry
Static water contact angles (WCA) in air and captive bubble contact angles (CBCA) underwater were determined with two different custom-built angle goniometers as previously reported. (). For static water contact angle measurements, a droplet (∼15 µL) of tri-distilled water was applied and for underwater contact angle measurements air bubbles (∼10–15 µL) were applied from below to the coating facing downwards. The shapes of the air bubbles were analyzed according to previous protocols. (). For both techniques, each value represents the average of at least three measurements on three different samples (n = 9), and given error bars represent the standard deviation.
2.4 Spectroscopic ellipsometry
The thickness of the coatings was monitored by a multiple wavelength ellipsometer (M-2000, J. A. Woollam Co., United States) according to previously established protocols. (; ). For modified surfaces with thicknesses below 60 nm, the surfaces were modeled as a single transparent layer with a wavelength-depending refractive index (Cauchy model: A = 1.45, B = 0.01, C = 0), and for modified surfaces with thickness above 60 nm, the surfaces were modeled as an absorbing layer. Values represent the average of at least three measurements on three different samples (n = 9) and given error bars represent the standard deviation.
2.5 Stability determination
The stability of the coatings was determined by under-water contact angle goniometry and spectroscopic ellipsometry. Coatings were immersed under dynamic conditions (linear shaker, 60 rpm) in 1 x PBS (pH = 7.4) for different durations. After 1 min, 10 min, 1 h, 3 h, 1 day, 2 days, and 7 days the captive bubble contact angles and thicknesses were determined. In addition, the sessile contact angle was determined, which indicates the value at the time 0 min. Each value represents the average of at least three measurements on three different samples (n = 9), and the error bars represent the standard deviation.
2.6 Surface plasmon resonance spectroscopy
Nonspecific protein adsorption of human serum albumin (HSA) and fibronectin (Fn) was determined using surface plasmon resonance spectroscopy (SRC7000DC, pump SR7500, autosampler SR7100, Reichert, United States) following previously established protocols. (; ; ). After baseline equilibration, HSA solutions (1 mg/mL) were injected over a period of 10 min at a flow rate of 10 μL/min. For Fn measurements, a concentration of 0.05 mg/mL was injected with a higher flow rate of 20 μL/min over a period of 10 min. Subsequently, 0.5 x PBS was injected to determine the amount of reversibly bound protein. The amount of irreversibly bound protein was determined from the SPR signal difference before the injection of the protein and after a PBS injection phase of 20 min. Each value represents the average of at least three measurements, and reported error bars represent the standard deviation.
2.7 L929 mouse fibroblasts adhesion assay
Cells of the L929 murine fibroblast cell line were obtained from DSMZ (German Collection of Microorganisms and Cell Cultures). L929 cells maintained in cell culture media RPMI 1640 with stable glutamine (PAN Biotech, Germany) containing 10% fetal bovine serum (FBS; PAN Biotech, Germany) under physiological culture conditions (37°C, 5% CO2), and subcultured using 0.25% Trypsin (Gibco, United States). The glass substrates with the coatings to be analyzed had a diameter of 20 mm. The cell number/volume of the L929 mouse fibroblasts was 100,000/mL. From this initial suspension, 200 µL (approx. 20,000 cells) were pipetted onto the central area of each sample surface and incubated for 3 h under standard cultivation conditions. Subsequently, 1 mL of fresh complete medium was added without rinsing the previously applied suspension away from the surface. All samples to be analyzed were then incubated for a further 20 h. The next day, brightfield microscopic live imaging of the sample surfaces was carried out. A customized live cell imaging system using the Olympus microscope type IX51 (Olympus, Germany) was used for this purpose. After the samples were removed from the cell culture incubator, they were immediately transferred to the microscope incubator so that the behavior of the cells could be observed under ideal cultivation conditions. Tissue culture polystyrene (TCPS, pro-cell adhesion, positive control) and polystyrene (PS, for suspension culture, negative control) served as control surfaces. Three replicate experiments (n = 3) were performed for each sample surface.
2.8 Surface cytotoxicity assay
To determine the cytotoxic effects of the surface modifications on L929 (German Collection of Microorganisms and Cell Cultures) a membrane integrity assay was performed (CytoTox™-ONE Homogeneous Membrane Integrity Assay, Promega, United States). Glass cover slips (ø 18 mm) modified with sample surfaces were placed in a 12-well-plate and fixed using 12-well plate inserts (CellCrown™12, Scaffdex, Finland). Sample sterilization was done by UV irradiation (UVC, ∼254 nm, 15 W) for 30 min and afterwards washed twice with DPBS (Gibco, United States). L929 were obtained as described previously. Cells [100,000 cells in 1 mL RPMI 1640 with stable glutamine (PAN Biotech, Germany) with 10% FBS (PAN Biotech, Germany)] were preincubated on substrate surfaces and two TCPS controls for 1 h at physiological culture conditions (37°C, 5% CO2) and followed by addition of 1 mL medium. Samples were incubated for 48 h in advance of the assay. Assay reagents were prepare as described by the distributor. For maximum LDH (lactate dehydrogenase) release, cells of one TCPS control were lysed using 0.1% TritonX-100 (for mol. Biology, Sigma Aldrich, Germany) for 10 min. The assay was performed as reported in the manual. Fluorescence was measured at ex/em 560 nm/590 nm (CLARIOstar Plus, BMG LABTECH, Germany). The results are displayed as relative LDH release compared to maximum LDH release Eq. (1). Measurement was performed in triplicates (n = 3).
2.9 Blood collection
Fresh human whole blood was obtained from healthy adult volunteers (no medication (e.g., aspirin) in the previous 2 weeks) by venipuncture into a S-Monovette 9 mL LH (Sarstedt, Nümbrecht, Germany). Blood was collected at the Centre for Translational Medicine, Medical Department I, University Hospital of the Ruhr-University Bochum, Herne, Germany according to appropriate legal and ethical guidelines. The participants provided written informed consent to participate in this study. The study was reviewed and approved by the Ethics Committee of the Medical Faculty of the Ruhr-University Bochum, Gesundheitscampus 33, D-44801 Bochum. The registration number of the study is 16-5,649.
2.10 Human thrombocytes adhesion assay
To perform the platelet adhesion assay, coverslips coated with the different polymers were placed individually into 6-well plates (one sample per well, PS). The samples were washed three times with 2 mL of a 0.9% (w/v) sodium chloride solution (B. Braun Melsungen, Germany) each, and shaken on a plate shaker for 1 min with 300 rpm at 37°C and dried. Fresh venous blood was collected via a peripheral arm vein as prescribed and transferred directly into lithium heparinate (LH) monovettes (S-Monovette 9 mL LH, SARSTEDT, Germany). The LH blood was centrifuged (5810 R, equipped with rotor A-4–62, Eppendorf, Germany) with 250 x g, 10 min at room temperature (RT). 200 μL of the clear phase (platelet-rich plasma, PRP) of the supernatant was diluted in 800 µL 0.9% (w/v) NaCl solution (1:4). 200 μL of the dilution were carefully placed on the glass coverslips. The samples were incubated for 1 h at 37°C at 200 rpm. Afterwards, the supernatant was removed, and the samples and controls were washed three times with 500 µL DPBS (GIBCO, Life Technologies, United Kingdom). The cells were fixed using 500 µL of a 4% (v/v) formaldehyde solution in DPBS for 30 min at RT. After the fixation solution was removed, the samples and controls were washed once with 500 µL DPBS each. Then 500 µL of a 0.4% (v/v) Triton X-100 solution (Molecular biology, Sigma-Aldrich, Germany) in DPBS was added to the cells for 10 min at RT. After disposal of the solution, the cells were washed once with 500 µL DPBS. The samples and controls were incubated for 1 h at RT in 500 µL of a 2% (w/v) BSA (≥96%, Sigma-Aldrich, Germany) solution in DPBS. The supernatant was discarded, and the cells stained with 200 µL of a 1:250 Phalloidin 546 (PromoFluor546 Labeled Phalloidin, PromoKine, Germany) in 2% (w/v) BSA solution per well. The cells were stained for 30 min at RT under light exclusion. Last, the samples were washed three times with 500 µL each of DPBS and dried. Fluorescence images were recorded using the Olympus IX51 microscope equipped with camera Olympus XM10 (Olympus, Germany) at Ex/Em = 551 nm/572 nm. A duplicate determination was carried out for each surface modification.
2.11 Whole blood adhesion assay
To analyze the adhesion of other blood components, the thrombocyte adhesion was repeated with whole blood. Two coverslips of each surface modification, including TCPS cover slips as control (ø 13 mm, Sarstedt, Germany) were placed inside wells of 6-well plates (one sample per well, PS). The different surface coatings and control were each washed once with 2 mL of a 0.9% (w/v) NaCl solution (B. Braun Melsungen, Germany) and shaken for 1 min at 300 rpm at 37°C. The samples were equilibrated in 2 mL of fresh NaCl solution for 30 min at 37°C prior incubation with undiluted LH blood for 1 h at 300 rpm and 37°C. The supernatant was removed, and the samples and controls were washed in DPBS (GIBCO, Life Technologies, United Kingdom) by dipping the cover slips several times. This was repeated two more times with fresh DPBS to remove unattached blood components. The cells were fixed and stained as described for thrombocyte adhesion. Microscopy was performed using the Olympus IX51 microscope equipped with camera Olympus XM10 (Olympus, Germany) at Ex/Em = 551 nm/572 nm.
2.12 Human erythrocytes-based dynamic hemolysis assay
To measure the hemolysis of human erythrocytes in contact with the polymer coatings, three samples of each surface modification were placed on coverslips in the wells of 6-well plates (one sample per well, PS). PS surfaces of a 24-well plate were used as controls (positive = hemolytic, negative = non-hemolytic). The different surface coatings to be analyzed and the negative control were each washed once with 1 mL of a 0.9% (w/v) NaCl solution (B. Braun Melsungen, Germany) and shaken on a plate shaker for 1 min at 300 rpm at 37°C. The washing solution was discarded, and the samples were equilibrated in 2,940 µL of fresh NaCl solution for 30 min at 37°C. The positive control was washed and equilibrated under the same conditions, using demineralised water instead of NaCl solution. The LH blood was diluted 4:5 in 0.9% NaCl solution. 60 μL of diluted LH blood was added to each equilibrated sample and control and incubated at 200 rpm and 37°C for 1 h. At the end of the incubation, each sample was treated at 400 rpm. From each sample and control, 950 µL of supernatant was transferred to a 1.5 mL reaction tube. The supernatants were centrifuged at 700 g for 10 min at room temperature (RT) (Centrifuge 5424 R with rotor FA-45–24-11, Eppendorf, Germany). Subsequently, 200 µL of the centrifuged supernatant was transferred to a 96-well plate (PS), and the absorbance was measured at 542 nm (CLARIOstar Plus, BMG LABTECH, Germany). The results were presented as hemolysis ratio (HR) in percent according to Eq. (2), where A is the absorbance of the sample, Cneg is the absorbance of the negative control and Cpos is the absorbance of the positive control. Samples and controls were analyzed in triplicate.
2.13 Human leucocyte activation assay
To investigate leukocyte activation of blood in contact with modified surfaces on coverslips, two samples of each modification were placed in a 6-well plate (one sample per well, PS). A PS surface was used as a negative control (duplicate). Samples and controls were disinfected once each with 3 mL of 70% (v/v) EtOH solution (Carl Roth, Germany), then washed once with 3 mL of 0.9% (w/v) NaCl solution (B. Braun Melsungen, Germany), and shaken on a plate shaker for 1 min at 300 rpm at 37°C. Venous blood was collected as described. To the samples and controls, 1.5 mL of LH blood was added and incubated at 37°C for 1 h at 200 rpm. As a positive control, 100 ng/mL lipopolysaccharide (LPS) from E. coli (Sigma Aldrich, Germany) was used. From each sample vial, 950 µL were transferred to a 1.5 mL reaction vial and centrifuged at 1,400 × g for 15 min at room temperature (RT). Meanwhile, the reagents for the polymorphonuclear (PMN) elastase assay (Demeditec Diagnostics, Germany) were prepared according to the manufacturer’s protocol. Briefly, 10 µL supernatant of the samples and the positive and negative controls were diluted 1:100 with calibrator/sample diluent (C/SD). 100 μL of controls and samples were added to the wells of a 96-well plate coated with polyclonal antibodies against PMN elastase. The samples were incubated for 1 h at 900 rpm and RT. The wells were then washed four times with 300 µL of 1x wash buffer before 150 µL of enzyme conjugate was added. After incubation under the same conditions, the wells were washed as before and 200 µL substrate solution was added. The plate was incubated for 20 min at RT with light excluded. 50 μL of stop solution was added, and absorbance was measured at 450 nm (CLARIOstar Plus, BMG LABTECH, Germany). Results were presented as leukocyte activation (LA) ratio in percent according to Eq. (3), where A is the absorbance of the sample, Cneg is the absorbance of the negative control, and Cpos is the absorbance of the positive control.
2.14 Statistical analysis of cytotoxicity and hemocompatibility assays
The values are reported as averages together with the standard deviation (the number of replicates is given in the results section). Statistical significance was determined using independent sample t-tests. The Bonferroni method was used to adjust for multiple comparisons. ().
2.15 Dynamic E. coli attachment assay
Cell cultivation of Escherichia coli K12 (E. coli, DSM 498) was conducted according to previously reported protocols for Cobetia marina bacteria. (). Though, the cultivation conditions were adapted for E. coli, so that Müller Hinton medium and an incubation temperature of 37°C were used. The attachment assay was conducted in M9 minimal medium with 1% glycerol on an orbital shaker at 60 rpm for 45 min with 7.5 ⋅ 106 cells/mL according to previously established protocols. (; ). ×80fields of view were recorded of adherent and with propidium iodide stained bacteria on coated microscopy slides using fluorescence microscopy (Texas Red filter set, Nikon Ti-E, ×10 objective Nikon CFI Plan Fluor DLL NA 0.3, Nikon Japan). The relative settlement density was determined by counting adherent bacterial cells. Outliers were removed when outside the 1.5 Interquartile range, and at least 60 fields of view per sample and three samples per coating were used to determine averages and standard deviations. Observed differences were tested for statistical significance with an ANOVA combined with a post hoc Tukey test at a significance level of α = 0.05.
2.16 Scanning electron microscopy
A scanning electron microscope (SEM, Quanta 3D FEG, FEI Company, Hillsboro, OR, United States) was used to image (20 kV, 3.0 spot size) the attachment of cellular components of human whole blood, the adhesion behavior of human thrombocytes and bacterial cells of an E. coli strain to the different surface coatings. Therefore, cultivated surfaces with whole blood or thrombocytes were fixed with 2.5% glutaraldehyde (50% in H2O, Sigma Aldrich, Germany) in DPBS (GIBCO, Life Technologies, United Kingdom) for 30 min followed by a triplicate wash with DPBS for 5 min. A secondary fixation was performed with 1% osmium tetraoxide (OsO4, ≥ 99, 95%, Carl Roth, Germany) in DPBS for 15 min, and samples were rinsed again as described above. Dehydration was performed in a series of increasing ethanol concentrations from 30, over 50, 70, 96 to finally three-fold 100% leaving the samples 5 min in each solution. The dehydrated samples were air-dried in advance of sputtering. Adherent E. coli cells were air-dried. The samples were coated with a ∼11 nm thick layer of gold using sputter coating deposition (Cressington Scientific Instruments Ltd, Watford, United Kingdom) before imaging to prevent charging effects during the measurements.
3 Results
Synthesis of pBMA, pSPe, and amphiphilic sulfobetaines was carried out according to previously established protocols via free radical co-polymerization. (). Within the amphiphilic polymers, the contents of BMA were varied from 10 to 50 mol%, and of SPe from 90 to 50 mol%, respectively. All formulations contain 1 mol% of BPEMA as photo-crosslinker (s. Figure 1). 1 wt% of polymer was dissolved in trifluoroethanol (TFE), spin coated onto amino propyl trimethoxy silane (APTMS) functionalized Si-surfaces, and cured by UV irradiation. (; ). The thickness of the obtained polymer coatings was determined by spectroscopic ellipsometry, and the wettability was characterized by contact angle goniometry (water contact angle WCA and captive bubble contact angle CBCA) (Table 1).
FIGURE 1
TABLE 1
| Sample | SPe content x [mol%]a | BMA content y [mol%]a | BPEMA content z [mol%]a | WCA [°] | CBCA [°] | Thickness [nm] |
|---|---|---|---|---|---|---|
| pBMA | - | 99 | 1 ± 0.3 | 78 ± 6 | 81 ± 2 | 97 ± 14 |
| cop-SPe-5-BMA-5 | 53 | 46 | 1 ± 0.3 | 60 ± 3 | 20 ± 1 | 108 ± 10 |
| cop-SPe-7-BMA-3 | 72 | 27 | 1 ± 0.3 | 59 ± 3 | 19 ± 2 | 104 ± 6 |
| cop-SPe-9-BMA-1 | 88 | 11 | 1 ± 0.3 | 36 ± 3 | 15 ± 2 | 120 ± 11 |
| pSPe | 99 | - | 1 ± 0.3 | 17 ± 3 | 13 ± 2 | 128 ± 10 |
Sample codes, composition, contact angles in air and water, and thickness of the polymer coatings. Reported CBCA values were determined immediately after immersion.
Data from Schardt et al. (), values are only reliable ±10 rel.% for SPe/BMA, content and ±50 rel.% for BPEMA, content.
Hydrophobic pBMA exhibits the highest WCA with 78° ± 6°. With increasing zwitterion content, the static WCA decreases. While the high WCA of pBMA remains similar directly after immersion, the CBCA of the SPe-containing coatings drops immediately down to 13°–20°. The differences in the contact angle of the amphiphilic polysulfobetaines as a function of BMA content can also be observed directly after immersion in water with cop-SPe-5-BMA-5 being the highest (20°) and pSPe being the lowest (13°), albeit some of the differences are within the error bars. At the same time, with an increase of the hydrophilic SPe content, the polar proportion of the surface energy also increases, while the dispersive proportion remains almost unchanged (cf. Supporting information, Supplementary Figure S1). All polymer coatings were incubated in 0.5 x PBS for up to 7 days with regular control of CBCA and layer thickness. Figure 2A shows that after the initial rearrangement, the SPe-containing polymers reveal nearly unchanged CBCAs between 13° and 25° over 7 days. For the hydrophobic pBMA, a steady decline of the CBCA down to 36° ± 5° is observed. To determine if the relative thickness changes over the immersion time of 7 days, thicknesses were also assessed at each time point and normalized to the initial values which were between 100 and 130 nm (Table 1). All coatings retain a thickness close to 100% (Figure 2B) with pBMA retaining constant layer thickness over the entire incubation and some of the zwitterionic coatings showing slightly higher thicknesses, albeit most of the changes are within the error bars.
FIGURE 2
Figure 3 shows the NSA of protein measurements with two different proteins. Compared to the negative control pBMA, all SPe-containing polymers exhibit an extremely low amount of NSA, for both HSA and Fn (p < 0.05). Within the amphiphilic series, all surfaces are highly resistant against the adsorption of both proteins and there are no significant differences in their ability to resist protein adsorption.
FIGURE 3
In accordance with DIN EN ISO 10993–5 (In vitro cytotoxicity analysis), the different coatings were brought into direct contact with the L929 mouse fibroblast cell line. Figure 4 shows the bright field live cell (BFLC) imaging microscopy after a cultivation period of approx. 24 h on the respective surfaces of pBMA, cop-SPe-5-BMA-5, cop-SPe-7-BMA-3, cop-SPe-9-BMA-1, pSPe, and the controls tissue culture polystyrene (TCPS) and polystyrene (PS).
FIGURE 4
Typical of TCPS (positive control for excellent cell adhesion), more than 95% of the initially seeded L929 mouse fibroblasts show strong adhesion after more than 20 h of standard cultivation (Figure 4A1). The cell bodies are also typically spread out on the surface and show multiple filopodia for palpation of the surface and contact with neighboring cells. In contrast, the L929 mouse fibroblasts on the PS surface, which is intended for cell proliferation in suspension culture, are only weakly adherent in the time window considered. With a few exceptions, they are almost exclusively round and not spread (Figure 4A2). On the pBMA surface, these cells show stronger adherence and lower nuclear-plasma ratio compared to PS, i.e., the L929 fibroblasts are slightly more spread (Figure 4A3). On the pSPe surface and the amphiphilic sulfobetaine surfaces, the L929 cells can no longer adhere. The BFLC images in Figure 4A4–A7 show only very few, round L929 cells that did not adhere to the surface coating. Figure 4A6 shows a surface section of coating cop-SPe-9-BMA-1, on which a few very mobile L929 cell aggregates can be seen. The sections shown in Figure 4A4–A7 are the only ones on which cells can be seen at all in relation to the total surfaces examined under the microscope (for details cf. Supporting information, Supplementary Table S2). A quantitative cell membrane integrity assay was used to prove that the prevention of cell adherence is not a cytotoxic effect. Figure 4B shows no cytotoxic effect during direct incubation of L929 cells compared to the TCPS standard surface.
In further experiments, the different polymer coatings were examined regarding their interaction with human platelets (platelet adhesion assay, Figure 5) and human whole blood (whole human LH blood adhesion assay, Figure 6) in accordance with DIN EN ISO 10993–4 (testing for interaction of biomaterials or medical devices with blood). For this purpose, the sample surfaces were incubated with platelet-enriched plasma (PRP) or LH whole blood under controlled dynamic conditions for 1 h. In Figures 5, 6, the FM images of the entire incubation surface of the control TCPS (A1) as well as the different coatings pBMA (B1), cop-SPe-5-BMA-5 (C1), cop-SPe-7-BMA-3 (D1), cop-SPe-9-BMA-1 (E1), and pSPe (F1) are shown under A1-F1. The surfaces TCPS as a positive control for cell adhesion and pBMA show strong platelet adhesion, spreading, and also partial aggregation in both tests. The observation of the respective SEM images shows no adhesion of other blood cells, but an additional increased adsorption of soluble blood components on the TCPS and pBMA sample surfaces incubated with LH whole blood. On the pSPe-modified surface (Figure 5F1–F3, Figure 6F1–F3), both the adhesion and the aggregate formation of the platelets are significantly reduced. As an example, on a pSPe surface incubated with LH whole blood, a coating defect with stronger platelet adhesion can be seen in the lower right image of the FM image (Figure 6F1). Apart from very few coating defects, the FM and SEM images for all surfaces with amphiphilic sulfobetaine coatings from cop-SPe-5-BMA-5 (Figure 5C1–C3, Figure 6C1–C3), cop-SPe-7-BMA-3 (Figure 5, Figure 6D1–D3) to cop-SPe-9-BMA-1 (Figure 5, Figure 6E1–E3) show that the extent of adhesion of human platelets decreases successively and aggregation is no longer visible. In addition, unlike on TCPS and pBMA, the high-resolution SEM images do not show adhesion of other cells or adsorption of other blood components.
FIGURE 5
FIGURE 6
The dynamic hemolysis assay was used to investigate whether freshly isolated human erythrocytes undergo cell membrane destabilization in contact with the different surface coatings, to release hemoglobin into the supernatant. Like the control surface PS, all the coatings examined showed no erythrotoxic effect in the sense of membrane destabilization and resulting hemolysis (Figure 7). For comparison, incubation with demineralised water and the resulting osmotic pressure leading to bursting of the RBCs provided the control value with complete hemolysis.
FIGURE 7
The extent of PMN elastase expression is an indicator of leukocyte activation, as inflammatory stimulation of neutrophils—the most abundant leukocytes—leads to a rapid release of large amounts of this proteolytic enzyme. Therefore, the release of PMN elastase after 1 h exposure of whole blood to the surface coatings pBMA, pSPe, cop-SPe-5-BMA-5, cop-SPe-7-BMA-3, and cop-SPe-9-BMA-1 was analyzed (Figure 8). None of the coatings showed a significant increase in leukocyte activity.
FIGURE 8
Besides protein resistance and hemocompatibility, also bacterial resistance is a key feature for implantable biomedical devices. Therefore, the resistance of the homo- and copolymer coatings against the attachment of the bacterium E. coli under dynamic conditions was tested (Figure 9). The SPe-containing polymers accumulate only 3%–7% of the E. coli density on pBMA. The reduction was in all cases statistically significant (p < 0.05). The lowest accumulations were found on cop-SPe-5-BMA-5 (3.3% ± 0.2%) and pSPe (4.3% ± 0.3%), followed by cop-SPe-9-BMA-1 (6.2% ± 0.4%) and cop-SPe-7-BMA-3 (7.0% ± 0.4%). When pBMA was included in the statistical analysis, no significant difference was seen between the different zwitterionic polymers (Figure 9). However, when restricting the statistical analysis only to the zwitterionic coatings, cop-SPe-5-BMA-5, and pSPe showed a statistically lower attachment compared to cop-SPe-9-BMA-1 and cop-SPe-7-BMA-3 (Figure 9 dotted line, p < 0.05). Single adherent bacteria are uniformly distributed on the different surface coatings (Figure 9B1–B5). The SEM images illustrate the integrity of the bacteria showing undamaged bacterial membranes (Figure 9C1–C5).
FIGURE 9
4 Discussion
Copolymerization of hydrophobic BMA with hydrophilic SPe yielded polymer coatings with variable amphiphilic character, which show high stability under physiological conditions. The amphiphilic character became obvious in the WCA measurements, as higher BMA contents enhanced the hydrophobicity of the coatings in the dry state. However, upon immersion in aqueous media (PBS), all the zwitterion-containing coatings showed a fast reorientation with strongly decreased CBCAs independent of their hydrophobic content. The low CBCAs indicate that the zwitterionic moieties accumulate at the interface while the hydrophobic moieties reorient inside the film. This is consistent with previous reports in which the reorientation behavior was studied in saltwater. (). A much slower and much less pronounced CBCA decrease was observed for pure pBMA reaching 36° ± 5° after 168 h. CBCA measurements in MilliQ water show a constant contact angle of 80° after 1 h immersion (), which is similar to the CBCAs of pBMA in PBS after 1 h. Literature reports that 7 days immersion of pBMA coatings in saltwater led to a reduction of the CBCA to approx. 55°. (). The even more pronounced reduction of the contact angle of pBMA in PBS seems therefore not solely attributed to the ion strength alone. We speculate that in particular, the interactions with the phosphates could be responsible for the observed decrease.
The resistance of the amphiphilic coatings against non-specific protein adsorption of proteins was tested against HSA and Fn. While HSA is the most abundant protein in blood, (), Fn is known to be involved in cell adhesion, migration, and differentiation processes. (; ; ). Pure pSPe and all amphiphilic coatings with up to 50% BMA content resist the NSA of HSA and Fn effectively. For both proteins, the NSA on pBMA is at least 16 times higher than on the zwitterionic samples. Even polymers with elevated contents of up to 50% BMA effectively suppressed the NSA of proteins (Figure 3). All coatings with low nonspecific protein adsorption showed low underwater contact angles with CBCAs ≤20°, which were observed even with high contents of the hydrophobic BMA. Previous studies have investigated the influence of increasing hydrophobic content in poly (oxanorbornene) by changing the length of peripheral alkyl chains from methyl over ethyl, butyl, hexyl to octyl. While ethyl and butyl groups do neither affect the wettability nor the NSA of proteins, an increase of the alkyl chain length from hexyl to octyl increased the WCA and CBCA substantially and increased the NSA of fibrinogen (Fg). (). Literature also reported that copolymers consisting of PC and BMA showed increasing resistance with increasing zwitterionic content with the highest resistance achieved by the highest zwitterionic content of 30%. (). Lin and co-workers copolymerized acrylate-based CB with BMA by free radical polymerization whereby the zwitterionic contents range from 17% to 82%. Copolymers with CB compositions higher than 31% detached from the surface. Simultaneously, copolymers with 31% CB content had the highest hydrophilicity and the lowest Fg adsorption. (). On the one hand, the detachment of the coatings with higher zwitterionic content can lead to a higher hydrophobicity. On the other hand, intra- and intermolecular charge compensation of the different zwitterionic groups may render the overall polymer more hydrophobic. (). The WCA of our samples increases with increasing hydrophobic content, however, this phenomenon is less pronounced under water (CBCA). No detachment was observed, even if the zwitterionic content was above 50%. This is probably due to the use of the adhesion promoting layer (APTMS) under, and of crosslinkers within the copolymers.
Body fluids and especially the acellular part of the blood, the plasma, have an extremely complex composition. If the water-soluble Fg, the main component of plasmatic coagulation, is removed from the plasma, then serum remains after centrifugation. Most invasive medical implants come into contact with blood, and thus, with a higher concentration of proteins. These can adsorb to biomaterial surfaces to varying degrees non-specifically. Subsequently, either cells circulating in the blood (platelets, erythrocytes, leucocytes, etc.) or, depending on the implantation site, localized connective tissue cells can adhere to the biomaterial surface contaminated with proteins, among other things. (; ; ; ). In this context, the cultivation experiments with L929 mouse fibroblasts seeded in RPMI medium with a 10% FCS addition on the surface coatings with 90–50 mol% SPe and pure pSPe show no tendency to adhere within 24 h despite the high serum protein content. This result is in line with the low NSA of HSA, Fn (Figure 3) and Fg () on these coatings as shown by the protein resistance measurements by SPR. As Fb and Fn are directly involved in many cell adhesion mechanisms, the NSA of these proteins is highly relevant for the cell adhesion process on the coatings. (). Hydrophilic SB-based coatings without fibroblast adhesion have been previously reported in the literature (; ), which is consistent with the high resistance of the pure pSPe coatings in our experiments. Also, amphiphilic coatings containing PC () or CB () as zwitterionic moiety have extensively been studied, successfully preventing fibroblast adhesion. Yet reports on the hemocompatibility and leukocyte activation of amphiphilic sulfobetaines with systematically changing amphiphilicity are still lacking in the literature. Even though there are significantly fewer L929 cells on the initially hydrophobic pBMA surfaces than on TCPS and PS, some cells show the formation of pseudopodia, spreading and thus adhesion to the surface. The mobility of the few fibroblasts is also comparable to that on PS, an observation that could be made during microscopy. Low NSA of proteins and decreased mobility of L929 can be seen on pBMA. Serum albumin and Fn are both components of FCS, increased NSA of these proteins may be associated with increased binding of L929 fibroblasts. (; ; ). In this context, the described correlation in the literature is supported by the simultaneous occurrence of high NSA of these proteins (Figure 3) and the reduced mobility of L929 on pBMA.
Platelets (also called thrombocytes) have a key function in the sum of physiological processes that cause bleeding to stop by clot formation. Specifically, they are at the beginning of a series of cascades called primary hemostasis. In the course of a vascular injury, in which, for example, the intima, i.e., the intraluminal endothelial cell layer, is damaged, proteins of the basal lamina lying below the endothelial cells, such as collagen IV and especially Fn, are exposed. This leads to rapid platelet adhesion, activation, and aggregation. (). Any insertion of a biomaterial in the form of an invasive implant, i.e., a foreign body, is first of all a potentially disruptive process to normal physiology. It is well known that the insertion of, for example, a temporary central venous or peripheral arterial catheter leads to the formation of blood clots on the inner wall of the catheter. It is also well known that platelets are responsible for this in the context of primary hemostasis, which spontaneously adhere to the foreign surface mediated by NSA of mainly Fg (), but also Fn() and other glycoproteins. (). Consequently, it is not surprising that platelets on the pBMA surface with low NSA resistance to Fg (), HSA and Fn show also pronounced adhesion and aggregation. In comparison, it is expected that when surfaces are coated with cop-SPe-5-BMA-5, cop-SPe-7-BMA-3, and cop-SPe-9-BMA-1, platelet adhesion decreases with increasing proportion of SPe. Indeed, on the intact pSPe surface, the number of adherent and aggregated platelets is significantly lower compared to the TCPS control and pBMA surface. Interestingly, however, it is larger than on the cop-SPe-9-BMA-1 surface. This illustrates that the previous experiments on blood glycoprotein adsorption alone are not sufficient to test the hemocompatibility of biomaterial surfaces, but only the interaction of primary blood cells (here primary human platelets) moving across and scanning the biomaterial surface with their pseudopodia, minute amounts of NSA blood proteins can be detected and lead to this minor platelet adhesion and aggregation on pSPe. Considering that from cop-SPe-5-BMA-5 via cop-SPe-7-BMA-3 to cop-SPe-9-BMA-1, the sulfobetaine 3-[N-2-(methacryloyloxy)ethyl-N,N-dimethyl]-ammonio propane-1-sulfonate (SPe) content increases but the amount of adhering platelets decreases, the particular importance of a specific molecular arrangement of the hydrophilic (SPe) and hydrophobic (BMA) portions of the coatings studied becomes more understandable under physiological conditions. The anti-platelet adhesion and activation properties of the poly (SPe-co-BMA) coincide with previous studies with poly (MPC-co-BMA) polymers. The hydrophilic MPC moiety seems to successfully suppress platelet adhesion and impart the non-thrombogenic properties of the coatings. (; ). A low platelet adhesion was also reported for poly (CBMA-co-BMA) with zwitterionic contents up to 30%. (). In the context of platelet adhesion and all subsequent platelet reactions with foreign material surfaces, the amphiphilic sulfobetaine-modified surfaces also showed a very good effect against unspecific interaction with or adsorption of soluble blood components in the whole blood experiment, as well as platelet adhesion (Figures 5, 6).
Another aspect of blood coming into contact with biomaterial surfaces is the interaction of red blood cells (RBC), the oxygen-transporting erythrocytes that make up the largest proportion of cells in blood, with the foreign material surface. Here it is important to exclude indirect or direct erythrotoxic effects that may lead to a loss of RBC membrane integrity and thus to hemolysis. (; ; ). From this perspective, we have also investigated the surface coatings described here with regard to their erythrotoxicity, following the work of van Oeveren () and Wang et al.. (). According to numerous scientific papers, a biomaterial is considered non-erythrotoxic if the measured hemolysis rate is less than 2%. (). This threshold is recommended in DIN EN ISO 10993–4 and ASTM F756-17. All surface coatings, including the amphiphilic ones with BMA contents up to 50%, investigated here are below this threshold and do not trigger any RBC membrane integrity loss and thus no hemolysis.
In addition to the platelets and the RBCs, neither of which has a cell nucleus, another cell nucleated, very heterogeneous cell population of the blood circulates through the human organism, the so-called white blood cells (WBCs) or leukocytes. These immunocompetent cells consist of granulocytes, lymphocytes, monocytes, mast cells, and dendritic cells. The segment-nucleated neutrophil granulocytes, casually referred to as neutrophils, account for the largest percentage of the total number of leukocytes (50%–70%). (). As soon as the physiological integrity of the organism is disturbed, such as by invasive pathogens, intended (surgery) or unintended (accident) injuries, or by the introduction of a temporary or permanent medical object, neutrophils immediately move to that site, attracted by so-called pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs). In the context of the relatively short activity period or life span of neutrophils, which is currently still very controversial in the literature and is put at 5–135 h, neutrophils are involved in the acute host-biomaterial interaction. (; ). In order to test this acute neutrophil reaction in interaction with the surface coatings under investigation here, a polymorphonuclear elastase (PMNE) assay was used. The enzyme PMNE is contained in the granules of neutrophils and released in the event of their activation by PAMPs or DAMPs. (; ). The lipopolysaccharide (LPS) used as a control in the study of the interaction of neutrophils with the surface coatings pBMA, cop-SPe-5-BMA-5, cop-SPe-7-BMA-3, cop-SPe-9-BMA-1, and pSPe, is a component of the outer layer of the outer cell membrane of Gram-negative bacteria such as E. coli, and is a so-called PAMP. Thus, this elicits a strong PMNE response. Since none of the surface modifications showed as strong an activation as LPS or, in comparison, not even a significant response in the PMNE ELISA assay, this can be taken as an additional preliminary positive indication that especially the coatings with 90–50 mol% of SPe should be further investigated for use in finishing invasive medical devices to improve their hemo- and immunocompatibility.
It has been reported that SPe-containing polymers can not only prevent the adhesion of proteins, but also of bacteria. (; ; ; ). The accumulated bacteria densities on all prepared zwitterion-containing coatings is <7% of the accumulation density on pBMA, and thus very low. Even an increase of the hydrophobic content of up to 50% creates still coatings with a high resistance to bacterial attachment and no formation of agglomerates can be seen. These findings show that the amphiphilic methacrylate copolymers containing hydrophilic sulfobetaine and hydrophobic butyl groups reduce bacterial attachment even at BMA contents of up to 50%. Our results concur well with previous studies in which copolymers composed of hydrophilic SB methacrylate with N-isopropyl acrylamide in 100:0, 70:30, 50:50, and 80:20 M ratios were shown to possess good protein resistance, low platelet adhesion, and resistance against the adhesion of human fibroblast and bacteria that increased with increasing zwitterionic content. (). In agreement with our data, even small quantities of SB or other zwitterionic components induced already high hydrophilicity of the resulting coatings. This could in part be the reason for the high resistance against the attachment of several cell types. (; ; ).
Our study clearly shows that a certain degree of amphiphilicity seems to be advantageous for antiadhesive biomedical coatings. Further investigations with even smaller quantities than 50% of SB-type monomers could complement these results shown here and may result in even improved coatings, or provide information on whether there is a minimum of SB required for antiadhesive, antithrombogenic, and immunocompatible coatings. Future work might also investigate the interactions with the complement system, in particular with the factors C3 and C5, before eventually conducting preclinical in vivo trials to surpass commercially available coatings.
5 Summary and conclusion
Biomedical applications place high demands on biocompatible coatings regarding the prevention of the non-specific adsorption of proteins, the non-specific adhesion of human cells, and pathogenic microorganisms such as bacteria. Zwitterionic coatings are promising candidates as due to their hydrophilic properties and high hydration they show a remarkable resistance against various accumulation processes. (; ; ). Here we were able to copolymerize hydrophilic SPe and hydrophobic BMA in different ratios to generate amphiphilic, easily applicable, photocrosslinkable polymer coatings. The resulting homo- and copolymer coatings are very stable in PBS solution and in addition, comprise a high content of SPe. The pure hydrophilic pSPe and also the amphiphilic coatings with up to 50% BMA are consequently very hydrophilic and provide high resistance against the NSA of proteins. The amphiphilic SPe/BMA copolymer coatings inhibit fibroblast adhesion without concomitant cytotoxicity and outperform the pure SPe coatings. The coatings also prevent the adhesion, activation, and thus aggregation of human platelets, not only when the platelets have been previously isolated, but also when the potential blood protein concentration was very high, as in the case of the whole blood experiments. In addition, they do not exhibit erythrotoxicity or leukocyte activation, and resist the adhesion of E. coli. The systematic increase of BMA moieties of up to 50% into the copolymers increased the hydrophobic properties of the coatings in the dry state but did not diminish the high hydrophilic properties in the wet state, i.e., the antiadhesive properties of the amphiphilic coatings were retained. Copolymers of SB and BMA can further reduce the self-assembly of the ionic groups and lead to a more rigid coating overall. In comparison to MPC- and CB-based polymers, SB moieties are less pH- and ion-responsive and not prone to degradation by hydrolysis. (). In combination with the high degree of cyto-, hemo-, and immunocompatibility results the investigated class of amphiphilic sulfobetaine-based polymer coatings are promising candidates for blood-related biomedical applications. In this context, further studies are needed to transfer these coatings from model glass surfaces to flexible polyurethane and silicone rubber material surfaces used for blood catheters and indwelling catheters in the urogenital tract.
Statements
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Ethics statement
The studies involving humans were approved by Ethics Committee of the Medical Faculty of the Ruhr University Bochum, Gesundheitscampus 33, D-44801 Bochum. The registration number of the study is 16–5649. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions
JK: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Supervision, Validation, Visualization, Writing–original draft, Writing–review and editing. DG: Data curation, Formal Analysis, Investigation, Methodology, Software, Validation, Visualization, Writing–original draft. AM: Formal Analysis, Investigation, Methodology, Writing–review and editing. RK: Investigation, Writing–review and editing. NB: Investigation, Writing–review and editing. US: Formal Analysis, Investigation, Supervision, Writing–review and editing. AL: Conceptualization, Data curation, Funding acquisition, Resources, Supervision, Writing–review and editing. RV: Funding acquisition, Writing–review and editing. JS: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing–original draft, Writing–review and editing. AR: Conceptualization, Data curation, Formal Analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Supervision, Validation, Writing–original draft, Writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The work was funded by the Deutsche Forschungsgemeinschaft (DFG), grants LA 611/14 and RO 2524/4, the Office of Naval Research (ONR) N0014-20-12244, and the European Union’s Horizon 2020 Research and Innovation Program, Grant Agreement No. 814495 (EvPro Project).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2024.1403654/full#supplementary-material
References
1
Arpa SancetM. P.HankeM.WangZ.BauerS.AzucenaC.ArslanH. K.et al (2013). Surface anchored metal-organic frameworks as stimulus responsive antifouling coatings. Biointerphases8, 29. 10.1186/1559-4106-8-29
2
BaggermanJ.SmuldersM. M. J.ZuilhofH. (2019). Romantic surfaces: a systematic overview of stable, biospecific, and antifouling zwitterionic surfaces. Langmuir35, 1072–1084. 10.1021/acs.langmuir.8b03360
3
BaierR. E. (2006). Surface behaviour of biomaterials: the theta surface for biocompatibility. J. Mat. Sci. Mat. Med.17, 1057–1062. 10.1007/s10856-006-0444-8
4
BauerS.FinlayJ. A.ThoméI.NolteK.FrancoS. C.RalstonE.et al (2016). Attachment of algal cells to zwitterionic self-assembled monolayers comprised of different anionic compounds. Langmuir32, 5663–5671. 10.1021/acs.langmuir.6b00839
5
BerndtM. C.MetharomP.AndrewsR. K. (2014). Primary haemostasis: newer insights. Haemophilia20, 15–22. 10.1111/hae.12427
6
BlackmanL. D.GunatillakeP. A.CassP.LocockK. E. S. (2019). An introduction to zwitterionic polymer behavior and applications in solution and at surfaces. Chem. Soc. Rev.48, 757–770. 10.1039/c8cs00508g
7
BullerJ.LaschewskyA.WischerhoffE. (2013). Photoreactive oligoethylene glycol polymers – versatile compounds for surface modification by thin hydrogel films. Soft Matter9, 929–937. 10.1039/C2SM26879E
8
ChangY.ChangW. J.ShihY. J.WeiT. C.HsiueG. H. (2011). Zwitterionic sulfobetaine-grafted poly(VINYLIDENE FLUORIDE) membrane with highly effective blood compatibility via atmospheric plasma-induced surface copolymerization. ACS Appl. Mat. Interfaces3, 1228–1237. 10.1021/am200055k
9
ChangY.YandiW.ChenW.-Y.ShihY.-J.YangC.-C.ChangY.et al (2010). Tunable bioadhesive copolymer hydrogels of thermoresponsive poly(N -isopropyl acrylamide) containing zwitterionic polysulfobetaine. Biomacromolecules11, 1101–1110. 10.1021/bm100093g
10
ChapmanR. G.OstuniE.TakayamaS.HolmlinR. E.YanL.WhitesidesG. M. (2000). Surveying for surfaces that resist the adsorption of proteins. J. Am. Chem. Soc.122, 8303–8304. 10.1021/ja000774f
11
ChenS.JiangS. (2008). An new avenue to nonfouling materials. Adv. Mat.20, 335–338. 10.1002/adma.200701164
12
ChengG.ZhangZ.ChenS.BryersJ. D.JiangS. (2007). Inhibition of bacterial adhesion and biofilm formation on zwitterionic surfaces. Biomaterials28, 4192–4199. 10.1016/j.biomaterials.2007.05.041
13
ColakS.TewG. N. (2012a). Amphiphilic polybetaines: the effect of side-chain hydrophobicity on protein adsorption. Biomacromolecules13, 1233–1239. 10.1021/bm201791p
14
ColakS.TewG. N. (2012b). Dual-functional ROMP-based betaines: effect of hydrophilicity and backbone structure on nonfouling properties. Langmuir28, 666–675. 10.1021/la203683u
15
CurtisA. S. G.ForresterJ. V. (1984). The competitive effects of serum proteins on cell adhesion. J. Cell. Sci.71, 17–35. 10.1242/jcs.71.1.17
16
DunJ.Osei-YeboahF.BoulasP.LinY.SunC. C. (2020). A systematic evaluation of poloxamers as tablet lubricants. Int. J. Pharm.576, 118994. 10.1016/j.ijpharm.2019.118994
17
DuongP. H. H.DaumannK.HongP. Y.UlbrichtM.NunesS. P. (2019). Interfacial polymerization of zwitterionic building blocks for high-flux nanofiltration membranes. Langmuir35, 1284–1293. 10.1021/acs.langmuir.8b00960
18
DuraiR.MownahA.NgP. C. H. (2009). Use of drains in surgery: a review. J. Perioper. Pract.19, 180–186. 10.1177/175045890901900603
19
EvansT. W. (2002). Review article: albumin as a drug—biological effects of albuminunrelated to oncotic pressure. Aliment. Pharmacol. Ther.16, 6–11. 10.1046/j.1365-2036.16.s5.2.x
20
FeneleyR. C. L.HopleyI. B.WellsP. N. T. (2015). Urinary catheters: history, current status, adverse events and research agenda. J. Med. Eng. Technol.39, 459–470. 10.3109/03091902.2015.1085600
21
GarcíaA. J.DucheyneP.BoettigerD. (1997). Quantification of cell adhesion using a spinning disc device and application to surface-reactive materials. Biomaterials18, 1091–1098. 10.1016/S0142-9612(97)00042-2
22
GnanasampanthanT.BeyerC. D.YuW.KarthäuserJ. F.WankaR.SpöllmannS.et al (2021). Effect of multilayer termination on nonspecific protein adsorption and antifouling activity of alginate-based layer-by-layer coatings. Langmuir37, 5950–5963. 10.1021/acs.langmuir.1c00491
23
GnanasampanthanT.KarthäuserJ. F.SpöllmannS.WankaR.BeckerH.-W.RosenhahnA. (2022). Amphiphilic alginate-based layer-by-layer coatings exhibiting resistance against nonspecific protein adsorption and marine biofouling. ACS Appl. Mat. Interfaces14, 16062–16073. 10.1021/acsami.2c01809
24
GrinnellF.FeldM. K. (1981). Adsorption characteristics of plasma fibronectin in relationship to biological activity. J. Biomed. Mat. Res.15, 363–381. 10.1002/jbm.820150308
25
Hall-StoodleyL.CostertonJ. W.StoodleyP. (2004). Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol.2, 95–108. 10.1038/nrmicro821
26
HaywardJ. A.ChapmanD. (1984). Biomembrane surfaces as models for polymer design: the potential for haemocompatibility. Biomaterials5, 135–142. 10.1016/0142-9612(84)90047-4
27
HeM.GaoK.ZhouL.JiaoZ.WuM.CaoJ.et al (2016). Zwitterionic materials for antifouling membrane surface construction. Acta Biomater.40, 142–152. 10.1016/j.actbio.2016.03.038
28
HeW.ZhouD.GuH.QuR.CuiC.ZhouY.et al (2023). A biocompatible 4D printing shape memory polymer as emerging strategy for fabrication of deployable medical devices. Macromol. Rapid Commun.44, 2200553. 10.1002/marc.202200553
29
HuangF.DingC.LiJ. (2018). Resisting protein but promoting cell adhesion by choline phosphate: a comparative study with phosphorylcholine. J. Bioresour. Bioprod.3, 3–8. 10.21967/jbb.v3i1.164
30
IshiharaK. (2019). Blood-compatible surfaces with phosphorylcholine-based polymers for cardiovascular medical devices. Langmuir35, 1778–1787. 10.1021/acs.langmuir.8b01565
31
IshiharaK.AragakiR.UedaT.WatenabeA.NakabayashiN. (1990a). Reduced thrombogenicity of polymers having phospholipid polar groups. J. Biomed. Mat. Res.24, 1069–1077. 10.1002/jbm.820240809
32
IshiharaK.IshikawaE.IwasakiY.NakabayashiN. (1999). Inhibition of fibroblast cell adhesion on substrate by coating with 2-methacryloyloxyethyl phosphorylcholine polymers. J. Biomater. Sci. Polym. Ed.10, 1047–1061. 10.1163/156856299X00676
33
IshiharaK.NomuraH.MiharaT.KuritaK.IwasakiY.NakabayashiN. (1998). Why do phospholipid polymers reduce protein adsorption?J. Biomed. Mat. Res.39, 323–330. 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
34
IshiharaK.OshidaH.EndoY.UedaT.WatanabeA.NakabayashiN. (1992). Hemocompatibility of human whole blood on polymers with a phospholipid polar group and its mechanism. J. Biomed. Mat. Res.26, 1543–1552. 10.1002/jbm.820261202
35
IshiharaK.UedaT.NakabayashiN. (1990b). Preparation of phospholipid polylners and their properties as polymer hydrogel membranes. Polym. J.22, 355–360. 10.1295/polymj.22.355
36
IulianoD. J.SaavedraS. S.TruskeyG. A. (1993). Effect of the conformation and orientation of adsorbed fibronectin on endothelial cell spreading and the strength of adhesion. J. Biomed. Mat. Res.27, 1103–1113. 10.1002/jbm.820270816
37
JiangS.CaoZ. (2010). Ultralow-fouling, functionalizable, and hydrolyzable zwitterionic materials and their derivatives for biological applications. Adv. Mat.22, 920–932. 10.1002/adma.200901407
38
KasákP.KronekováZ.KrupaI.LacíkI. (2011). Zwitterionic hydrogels crosslinked with novel zwitterionic crosslinkers: synthesis and characterization. Polym. Guildf.52, 3011–3020. 10.1016/j.polymer.2011.04.056
39
KocJ.SchönemannE.AmuthalingamA.ClarkeJ.FinlayJ. A.ClareA. S.et al (2019). Low fouling thin hydrogel coatings made of photo-crosslinked polyzwitterions. Langmuir35, 1552–1562. 10.1021/acs.langmuir.8b02799
40
KoschitzkiF.WankaR.SobotaL.GardnerH.HunsuckerK. Z.SwainW.et al (2021). Amphiphilic zwitterionic acrylate/methacrylate copolymers for marine fouling-release coatings. Langmuir37, 5591–5600. 10.1021/acs.langmuir.1c00428
41
KoschitzkiF.WankaR.SobotaL.KocJ.GardnerH.HunsuckerK. Z.et al (2020). Amphiphilic dicyclopentenyl/carboxybetaine-containing copolymers for marine fouling-release applications. ACS Appl. Mat. Interfaces12, 34148–34160. 10.1021/acsami.0c07599
42
LalaniR.LiuL. (2012). Electrospun zwitterionic poly(sulfobetaine methacrylate) for nonadherent, superabsorbent, and antimicrobial wound dressing applications. Biomacromolecules13, 1853–1863. 10.1021/bm300345e
43
LaschewskyA.RosenhahnA. (2019). Molecular design of zwitterionic polymer interfaces: searching for the difference. Langmuir35, 1056–1071. 10.1021/acs.langmuir.8b01789
44
LeeJ.YiS.HongK. D.SeoJ. H. (2021). Copolymerization of zwitterionic carboxybetaine and various hydrophobic groups to optimize antifouling and biocompatible properties. J. Ind. Eng. Chem.96, 284–293. 10.1016/j.jiec.2021.01.034
45
LiB.JainP.MaJ.SmithJ. K.YuanZ.HungH. C.et al (2019). Trimethylamine N-oxide–derived zwitterionic polymers: a new class of ultralow fouling bioinspired materials. Sci. Adv.5, eaaw9562–10. 10.1126/sciadv.aaw9562
46
LiB.YuanZ.HungH.MaJ.JainP.TsaoC.et al (2018). Revealing the immunogenic risk of polymers. Angew. Chem. Int. Ed.57, 13873–13876. 10.1002/anie.201808615
47
LiG.XueH.ChengG.ChenS.ZhangF.JiangS. (2008). Ultralow fouling zwitterionic polymers grafted from surfaces covered with an initiator via an adhesive mussel mimetic linkage. J. Phys. Chem. B112, 15269–15274. 10.1021/jp8058728
48
LinX.FukazawaK.IshiharaK. (2015). Photoreactive polymers bearing a zwitterionic phosphorylcholine group for surface modification of biomaterials. ACS Appl. Mat. Interfaces7, 17489–17498. 10.1021/acsami.5b05193
49
LinX.JainP.WuK.HongD.HungH. C.O’KellyM. B.et al (2019). Ultralow fouling and functionalizable surface Chemistry based on zwitterionic carboxybetaine random copolymers. Langmuir35, 1544–1551. 10.1021/acs.langmuir.8b02540
50
LinX.WuK.ZhouQ.JainP.BoitM. O. K.LiB.et al (2020). Photoreactive carboxybetaine copolymers impart biocompatibility and inhibit plasticizer leaching on polyvinyl chloride. ACS Appl. Mat. Interfaces12, 41026–41037. 10.1021/acsami.0c09457
51
LiuP.ChenQ.LiL.LinS.ShenJ. (2014). Anti-biofouling ability and cytocompatibility of the zwitterionic brushes-modified cellulose membrane. J. Mat. Chem. B2, 7222–7231. 10.1039/c4tb01151a
52
LoweA. B.McCormickC. L. (2002). Synthesis and solution properties of zwitterionic polymers. Chem. Rev.102, 4177–4190. 10.1021/cr020371t
53
MaciasS. L.KeselowskyB. G. (2022). Perspectives on immunometabolism at the biomaterials interface. Mol. Asp. Med.83, 100992. 10.1016/j.mam.2021.100992
54
MakiD. G.KlugerD. M.CrnichC. J. (2006). The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin. Proc.81, 1159–1171. 10.4065/81.9.1159
55
MiL.JiangS. (2014). Integrated antimicrobial and nonfouling zwitterionic polymers. Angew. Chem. - Int. Ed.53, 1746–1754. 10.1002/anie.201304060
56
NakayaT.LiY. J. (1999). Phospholipid polymers. Prog. Polym. Sci.24, 143–181. 10.1016/s0079-6700(98)00015-x
57
NobleW. S. (2009). How does multiple testing correction work?Nat. Biotechnol.27, 1135–1137. 10.1038/nbt1209-1135
58
PacharraS.McMahonS.DuffyP.BasnettP.YuW.SeiselS.et al (2020). Cytocompatibility evaluation of a novel series of PEG-functionalized lactide-caprolactone copolymer biomaterials for cardiovascular applications. Front. Bioeng. Biotechnol.8, 991–1015. 10.3389/fbioe.2020.00991
59
PacharraS.OrtizR.McMahonS.WangW.ViebahnR.SalberJ.et al (2019). Surface patterning of a novel PEG-functionalized poly-l-lactide polymer to improve its biocompatibility: applications to bioresorbable vascular stents. J. Biomed. Mat. Res. Part B Appl. Biomater.107, 624–634. 10.1002/jbm.b.34155
60
PaschkeS.LienkampK. (2020). Polyzwitterions: from surface properties and bioactivity profiles to biomedical applications. ACS Appl. Polym. Mat.2, 129–151. 10.1021/acsapm.9b00897
61
PaschkeS.MarxF.BleicherV.EickenscheidtA.LienkampK. (2022). Poly(oxanorbornene)-Based polyzwitterions with systematically increasing hydrophobicity: synthesis, physical characterization, and biological properties. Macromol. Chem. Phys.2200334, 1–13. 10.1002/macp.202200334
62
PodsiedlikM.Markowicz-PiaseckaM.SikoraJ. (2020). Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery. Chem. Biol. Interact.332, 109305. 10.1016/j.cbi.2020.109305
63
PruckerO.BrandstetterT.RüheJ. (2018). Surface-attached hydrogel coatings via C,H-insertion crosslinking for biomedical and bioanalytical applications (Review). Biointerphases13, 010801. 10.1116/1.4999786
64
SafdarN.O’HoroJ. C.MakiD. G. (2013). Arterial catheter-related bloodstream infection: incidence, pathogenesis, risk factors and prevention. J. Hosp. Infect.85, 189–195. 10.1016/j.jhin.2013.06.018
65
SchardtL.Martínez GuajardoA.KocJ.ClarkeJ. L.FinlayJ. A.ClareA. S.et al (2022). Low fouling polysulfobetaines with variable hydrophobic content. Macromol. Rapid Commun.43, 2100589. 10.1002/marc.202100589
66
SchönemannE.KocJ.KarthäuserJ. F.ÖzcanO.SchanzenbachD.SchardtL.et al (2021). Sulfobetaine methacrylate polymers of unconventional polyzwitterion architecture and their antifouling properties. Biomacromolecules22, 1494–1508. 10.1021/acs.biomac.0c01705
67
SchönemannE.LaschewskyA.RosenhahnA. (2018). Exploring the long-term hydrolytic behavior of zwitterionic polymethacrylates and polymethacrylamides. Polym. (Basel)10, 639. 10.3390/polym10060639
68
SchwarzeJ.WankaR.RosenhahnA. (2020). Microfluidic accumulation assay to quantify the attachment of the marine bacterium Cobetia marina on fouling-release coatings. Biointerphases15, 031014. 10.1116/6.0000240
69
SegalA. W. (2005). How neutrophils kill microbes. Annu. Rev. Immunol.23, 197–223. 10.1146/annurev.immunol.23.021704.115653
70
ShaoQ.HeY.JiangS. (2011). Molecular dynamics simulation study of ion interactions with zwitterions. J. Phys. Chem. B115, 8358–8363. 10.1021/jp204046f
71
ShaoQ.HeY.WhiteA. D.JiangS. (2010). Difference in hydration between carboxybetaine and sulfobetaine. J. Phys. Chem. B114, 16625–16631. 10.1021/jp107272n
72
ShaoQ.JiangS. (2014). Influence of charged groups on the properties of zwitterionic moieties: a molecular simulation study. J. Phys. Chem. B118, 7630–7637. 10.1021/jp5027114
73
ShastriV. (2003). Non-degradable biocompatible polymers in medicine: past, present and future. Curr. Pharm. Biotechnol.4, 331–337. 10.2174/1389201033489694
74
SoundararajanA.Muralidhar RJ.DhandapaniR.RadhakrishnanJ.ManigandanA.KalyanasundaramS.et al (2018). Surface topography of polylactic acid nanofibrous mats: influence on blood compatibility. J. Mat. Sci. Mat. Med.29, 145–214. 10.1007/s10856-018-6153-2
75
StachM.KronekováZ.KasákP.KollárJ.PentrákM.MičušíkM.et al (2011). Polysulfobetaine films prepared by electrografting technique for reduction of biofouling on electroconductive surfaces. Appl. Surf. Sci.257, 10795–10801. 10.1016/j.apsusc.2011.07.102
76
SteeleJ. G.JohnsonG.UnderwoodP. A. (1992). Role of serum vitronectin and fibronectin in adhesion of fibroblasts following seeding onto tissue culture polystyrene. J. Biomed. Mat. Res.26, 861–884. 10.1002/jbm.820260704
77
StruczyńskaM.Firkowska‐BodenI.LevandovskyN.HenschlerR.KassirN.JandtK. D. (2023). How crystallographic orientation‐induced fibrinogen conformation affects platelet adhesion and activation on TiO 2. Adv. Healthc. Mat.12, 2202508. 10.1002/adhm.202202508
78
SuojanenJ. N.BrophyD. P.NasserI. (2000). Thrombus on indwelling central venous catheters: the histopathology of “fibrin sheaths.”. Cardiovasc. Interv. Radiol.23, 194–197. 10.1007/s002700010042
79
ThomeI.PettittM. E.CallowM. E.CallowJ. A.GrunzeM.RosenhahnA. (2012). Conditioning of surfaces by macromolecules and its implication for the settlement of zoospores of the green alga Ulva linza. Biofouling28, 501–510. 10.1080/08927014.2012.689288
80
TomerN.GardenE.SmallA.PaleseM. (2021). Ureteral stent encrustation: epidemiology, pathophysiology, management and current Technology. J. Urol.205, 68–77. 10.1097/JU.0000000000001343
81
van OeverenW. (2013). Obstacles in haemocompatibility testing. Sci. (Cairo)2013, 1–14. 10.1155/2013/392584
82
van WachemP. B.MallensB. W. L.DekkerA.BeugelingT.FeijenJ.BantjesA.et al (1987). Adsorption of fibronectin derived from serum and from human endothelial cells onto tissue culture polystyrene. J. Biomed. Mat. Res.21, 1317–1327. 10.1002/jbm.820211104
83
VeerachamyS.YarlagaddaT.ManivasagamG.YarlagaddaP. K. (2014). Bacterial adherence and biofilm formation on medical implants: a review. Proc. Inst. Mech. Eng. Part H. J. Eng. Med.228, 1083–1099. 10.1177/0954411914556137
84
VenaultA.ChangY. (2019). Designs of zwitterionic interfaces and membranes. Langmuir35, 1714–1726. 10.1021/acs.langmuir.8b00562
85
WalkerE. J.PandiyarajanC. K.EfimenkoK.GenzerJ. (2019). Generating surface-anchored zwitterionic networks and studying their resistance to bovine serum albumin adsorption. ACS Appl. Polym. Mat.1, 3323–3333. 10.1021/acsapm.9b00772
86
WangJ.HeY.MaitzM. F.CollinsB.XiongK.GuoL.et al (2013). A surface-eroding poly(1,3-trimethylene carbonate) coating for fully biodegradable magnesium-based stent applications: toward better biofunction, biodegradation and biocompatibility. Acta Biomater.9, 8678–8689. 10.1016/j.actbio.2013.02.041
87
WardW. K. (2008). A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis. J. Diabetes Sci. Technol.2, 768–777. 10.1177/193229680800200504
88
WuA.GaoY.ZhengL. (2019). Zwitterionic amphiphiles: their aggregation behavior and applications. Green Chem.21, 4290–4312. 10.1039/c9gc01808e
89
WuH.LeeC. J.WangH.HuY.YoungM.HanY.et al (2018). Highly sensitive and stable zwitterionic poly(sulfobetaine-3,4-ethylenedioxythiophene) (PSBEDOT) glucose biosensor. Chem. Sci.9, 2540–2546. 10.1039/c7sc05104b
90
YangW.XueH.CarrL. R.WangJ.JiangS. (2011). Zwitterionic poly(carboxybetaine) hydrogels for glucose biosensors in complex media. Biosens. Bioelectron.26, 2454–2459. 10.1016/j.bios.2010.10.031
91
ZanderZ. K.BeckerM. L. (2018). Antimicrobial and antifouling strategies for polymeric medical devices. ACS Macro Lett.7, 16–25. 10.1021/acsmacrolett.7b00879
92
ZhangL.CaoZ.BaiT.CarrL.Ella-MenyeJ. R.IrvinC.et al (2013). Zwitterionic hydrogels implanted in mice resist the foreign-body reaction. Nat. Biotechnol.31, 553–556. 10.1038/nbt.2580
93
ZhengL.SundaramH. S.WeiZ.LiC.YuanZ. (2017). Applications of zwitterionic polymers. React. Funct. Polym.118, 51–61. 10.1016/j.reactfunctpolym.2017.07.006
94
ZindelJ.KubesP. (2020). DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu. Rev. Pathol. Mech. Dis.15, 493–518. 10.1146/annurev-pathmechdis-012419-032847
Summary
Keywords
polyzwitterion, antiadhesive, hydrogels, benzophenone methacrylate, platelet adhesion, thrombocyte activation
Citation
Karthäuser JF, Gruhn D, Martínez Guajardo A, Kopecz R, Babel N, Stervbo U, Laschewsky A, Viebahn R, Salber J and Rosenhahn A (2024) In vitro biocompatibility analysis of protein-resistant amphiphilic polysulfobetaines as coatings for surgical implants in contact with complex body fluids. Front. Bioeng. Biotechnol. 12:1403654. doi: 10.3389/fbioe.2024.1403654
Received
19 March 2024
Accepted
19 June 2024
Published
17 July 2024
Volume
12 - 2024
Edited by
Krishna Pramanik, National Institute of Technology Rourkela, India
Reviewed by
Qian Li, Texas A and M University, United States
Sajeeshkumar Madhurakkat Perikamana, Duke University, United States
Updates
Copyright
© 2024 Karthäuser, Gruhn, Martínez Guajardo, Kopecz, Babel, Stervbo, Laschewsky, Viebahn, Salber and Rosenhahn.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jochen Salber, jochen.salber@ruhr-uni-bochum.de; Axel Rosenhahn, axel.rosenhahn@ruhr-uni-bochum.de
† These authors have contributed equally to this work
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.